NOxy Health Products, LLC
🇺🇸United States
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers
Phase 1
Recruiting
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Drug: NOX1416 and SOCProcedure: SOC (Standard of care)
- First Posted Date
- 2024-05-07
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- NOxy Health Products, LLC
- Target Recruit Count
- 40
- Registration Number
- NCT06402565
- Locations
- 🇺🇸
Prohealth Research Center, Doral, Florida, United States
🇺🇸Family First Medical Research Center, Hialeah Gardens, Florida, United States
NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers (NTCDU)
Phase 1
Suspended
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Drug: NOX-1416+SOCOther: Placebo+SOC
- First Posted Date
- 2023-08-31
- Last Posted Date
- 2024-01-16
- Lead Sponsor
- NOxy Health Products, LLC
- Target Recruit Count
- 30
- Registration Number
- NCT06020664
- Locations
- 🇮🇱
Soroka Medical Center (Site 106), Beersheba, Israel
🇮🇱Carmel Medical Center (Site 104), Haifa, Israel
🇮🇱Shaare Zedek Hospital (site 101), Jerusalem, Israel
News
No news found